会计年度:2021-12-31收入分布
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 合计 | 3,335,970,889.11 | 1,472,785,128.52 | 1,863,185,760.59 | 55.85 |
| 其他(补充) | 63,047,517.09 | 8,010,636.70 | 55,036,880.39 | 87.29 |
| 医药制造 | 2,719,881,815.02 | 1,116,013,656.17 | 1,603,868,158.85 | 58.97 |
| 医用器械 | 553,041,557.00 | 348,760,835.65 | 204,280,721.35 | 36.94 |
|
会计年度:2021-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 成品药业务 | 1,082,398,670.63 | 440,089,880.85 | 642,308,789.78 | 59.34 |
| 分部间抵销 | -530,998,400.38 | -496,317,650.51 | -34,680,749.87 | 6.53 |
| 合计 | 1,659,912,037.16 | 741,242,824.68 | 918,669,212.48 | 55.34 |
| 其他业务 | 71,037,318.59 | 5,816,280.52 | 65,221,038.07 | 91.81 |
| 医疗器械业务 | 249,591,687.71 | 156,492,128.33 | 93,099,559.38 | 37.30 |
| 原料药业务 | 787,882,760.61 | 635,162,185.49 | 152,720,575.12 | 19.38 |
|
会计年度:2020-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 成品药业务 | 2,053,281,316.52 | 570,452,906.14 | 1,482,828,410.38 | 72.22 |
| 分部间抵销 | -1,088,505,560.21 | -723,239,002.03 | -365,266,558.18 | 33.56 |
| 合计 | 3,258,075,481.25 | 1,273,328,310.09 | 1,984,747,171.16 | 60.92 |
| 其他业务 | 132,369,514.81 | 13,105,614.03 | 119,263,900.78 | 90.10 |
| 医用器械业务 | 450,247,305.04 | 279,666,277.02 | 170,581,028.02 | 37.89 |
| 原料药业务 | 1,710,682,905.09 | 1,133,342,514.93 | 577,340,390.16 | 33.75 |
|
会计年度:2020-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 成品药业务 | 1,159,823,784.84 | 422,939,770.75 | 736,884,014.09 | 63.53 |
| 分部间抵销 | -567,677,656.71 | -561,493,457.73 | -6,184,198.98 | 1.09 |
| 合计 | 1,640,533,883.14 | 618,387,082.46 | 1,022,146,800.68 | 62.31 |
| 其他 | 45,015,022.83 | 5,926,417.40 | 39,088,605.43 | 86.83 |
| 其他(补充) | 20,819,335.14 | 5,184,696.14 | 15,634,639.00 | 75.10 |
| 医用显示器业务 | 201,331,229.26 | 120,833,656.54 | 80,497,572.72 | 39.98 |
| 原料药业务 | 802,041,502.92 | 630,180,695.50 | 171,860,807.42 | 21.43 |
| 主营业务收入 | 1,619,714,548.00 | 613,202,386.32 | 1,006,512,161.68 | 62.14 |
|
会计年度:2019-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 成品药业务 | 2,371,308,163.26 | 733,539,015.68 | 1,637,769,147.58 | 69.07 |
| 分部间抵销 | -1,139,685,757.46 | -1,073,894,081.85 | -65,791,675.61 | 5.77 |
| 合计 | 3,646,683,905.76 | 1,273,428,846.48 | 2,373,255,059.28 | 65.08 |
| 其他业务 | 122,220,873.71 | 15,161,833.67 | 107,059,040.04 | 87.59 |
| 其他业务收入 | 42,232,255.64 | 13,010,092.83 | 29,222,162.81 | 69.19 |
| 医用器械业务 | 474,601,360.51 | 276,373,580.34 | 198,227,780.17 | 41.77 |
| 原料药业务 | 1,818,239,265.74 | 1,322,248,498.64 | 495,990,767.10 | 27.28 |
| 主营业务收入 | 3,604,451,650.12 | 1,260,418,753.65 | 2,344,032,896.47 | 65.03 |
|
1/8 转到 
